ArticleBrazilian oral research2025
Antibacterial resorbable barrier membranes with therapeutic activity for guided tissue regeneration.
Article in Brazilian oral research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this study was to develop a bioabsorbable membrane composed of poly(butylene adipate-co-terephthalate) (PBAT) with alkyl trimethyl ammonium bromide (ATAB) to provide antimicrobial properties. Membranes were manufactured via the solvent casting technique using chloroform solutions containing PBAT and varying concentrations of ATAB (1, 2.5, and 5% wt), with ATAB-free membranes as a control. The characterization of the membranes included assessments of contact angle, surface free energy, and degradation in distilled water over periods of one week, one month, and three months. Mechanical properties were evaluated via tensile strength, and changes in water pH were monitored from 24 hours to three months post-immersion. Cytotoxicity was assessed using gingival fibroblasts and pre-osteoblasts via the SRB assay. Antimicrobial activity was tested against Staphylococcus aureus. ATAB inclusion reduced water contact angle and increased surface free energy compared to controls (p < 0.001). The addition of 5% wt ATAB decreased the tensile strength of PBAT membranes. At one month, a reduced mass was observed for the 2.5% wt ATAB membrane. The specimens' mass was reduced for all groups after three months of immersion in water in comparison to the initial measurement, while a reduction in thickness was found in all time points, without the influence of ATAB. ATAB incorporation reduced cell viability. Antimicrobial efficacy, resulting in a > 3 log10 bacterial reduction, was observed for S. aureus at the 5% wt concentration. The addition of 2.5% wt ATAB to PBAT membranes may be a suitable strategy to generate barrier membranes with an antibacterial effect while maintaining acceptable mechanical and surface properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.